Investors In Maker Of Failed COVID Test Want Class Certified

By Mark Payne · October 16, 2023, 5:16 PM EDT

A group of investors suing a biotech company that failed to launch a COVID-19 diagnostic test promoted in the run-up to the firm's IPO urged a California federal court to certify...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

IN RE Talis Biomedical Securities Litigation

Case Number

Court

California Northern

Nature of Suit

Securities/Commodities

Date Filed

January 07, 2022

Recent Articles By Mark

July 11, 2024
Sens. Say Medical Debt Acute 'Symptom' Of Chronic Issues
July 09, 2024
Kroger Deal's Local Veto May Give Ore. Health Agency Pause
July 02, 2024
Abortion, Trans Healthcare Top Lower Court Litigation
July 01, 2024
House Republicans Call For ACA Enrollment Probe
June 28, 2024
Shifting Legal Positions Behind High Court Abortion Punt
June 27, 2024
High Court Allows Idaho Emergency Abortions, For Now
June 26, 2024
High Court 'Inadvertently' Posts Order Punting Abortion Case
June 25, 2024
NBA Fraud Trial, An HHS Loss, And An Ivy League Doc Settles
June 25, 2024
The Federal Judge At The Center Of NC Abortion Battles
June 11, 2024
High Court On Familiar Ground In Hospital Pay Row